Experiment 397331

Worktypes

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismGinkgo biloba (GINKGOACEAE)
CitationKNIPSCHILD,PG: HOERR,R: OSCHMANN,R: VAN ROSSUM,E: VAN DONGEN,MCJM:. (1998). OPTIMIZATION OF PLACEBOS FOR DOUBLE-BLIND CLINICAL TRIALS. EXPERIENCE WITH A PHYTOPHARMACEUTICAL.. 48(10)
Amount utilized
Compound isolated
DiseaseA DOUBLE-BLIND, PLACEBO-CONTROLLED ASSESSED THE EFFICACY OF GINKGO BILOBA IN AGE-ASSOCIATED MEMORY IMPAIRMENT. PATIENTS WERE TREATED WITH 240 MG, 160 MG OR PLACEBO FOR 3 MONTHS, AFTER WHICH HALF OF THE PATIENTS WERE SWITCHED TO PLACEBO FOR A FURTHER 3 MONTHS. A DETAILED DESCRIPTION OF THE PLACEBO USED DURING THIS STUDY IS INCLUDED. A COMMERCIAL PRODUCT, EGB-761, WAS USED.
Dose amountVAR
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
ExtractETOH(100%)EXT
GenderGIVEN TO BOTH SEXES